Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Q-linea AB ( (SE:QLINEA) ) has shared an announcement.
Q-linea AB has announced a reverse share split, consolidating 1,000 shares into one, effective from 15 July 2025. This move, which reduces the total number of shares significantly, is intended to adjust the share price and streamline the company’s equity structure, with no required action from shareholders as the process will be managed automatically by Euroclear Sweden AB.
More about Q-linea AB
Q-linea is a healthcare company specializing in rapid antimicrobial susceptibility testing systems, particularly the ASTar® system, which aids hospitals in quickly determining optimal treatments for bloodstream infections and sepsis. Headquartered in Uppsala, Sweden, Q-linea operates globally with regional offices in Italy and the USA, and its products are CE-IVD marked and FDA 510(k) cleared.
Average Trading Volume: 30,015,237
Current Market Cap: SEK412.1M
Find detailed analytics on QLINEA stock on TipRanks’ Stock Analysis page.